INDIA BUSINESS WORLD - MAY 11^th - MAY 31^st - 2008

CADILA GETS FDA NOD TO MARKET FOUR DRUGS

Pharma major Zydus Cadila has said it has received approval from Food and Drug Administration (FDA) to market four products, including antidepressant Escitalopram Oxalate tablets in the US. The group has received FDA approval to market 10, 20, 40, 80 mg of Pravastatin Sodium tablets in the US, Cadila Healthcare said in a filing to BSE. Cadila has also received tentative approval to market Escitalopram Oxalate and Losartam Potassium tablets.